Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Le informazioni sui progetti di Orizzonte 2020 e ora anche le relative sintesi delle relazioni sono disponibili su CORDIS. Tutti i progetti H2020 possono essere scaricati dal Portale Open Data dell'UE .

My refinements


Download results of this page


Perfeziona per:

Programma

Paese

Austria (2)
Belgio (4)
Cipro (2)
Croazia (1)
Danimarca (1)
Estonia (1)
Finlandia (2)
Francia (2)
Germania (8)
Grecia (5)
India (1)
Irlanda (3)
Israele (2)
Italia (8)
Norvegia (1)
Paesi Bassi (8)
Polonia (2)
Portogallo (1)
Regno Unito (7)
Russia (1)
Serbia (3)
Slovenia (1)
Spagna (6)
Stati Uniti (3)
Svezia (2)
Svizzera (3)

Lingua

English (10)

Ricerca avanzata

Results 1 - 10 of 10
Order by: Results/page:
1
Dynamic MOdelling of REsilience
[PROGETTO] DynaMORE - Dynamic MOdelling of REsilience
ID: 777084
Data di inizio: 2018-04-01, Termine: 2023-03-31
The project DynaMORE (Dynamic MOdelling of REsilience) exploits advanced mathematical modelling for the promotion of mental health and well-being. DynaMORE will generate the first personalised in-silico model of mental health in the face of adversity, that is, stress...
Programme: H2020-EU.3.1.5.
Record Number: 216475
Last updated on: 2018-07-26
In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy
ID: 777204
Data di inizio: 2018-06-01, Termine: 2021-11-30
According to the 2014 European Society of Cardiology Guidelines, cardiomyopathies are defined as structural and functional abnormalities of the ventricular myocardium that are unexplained by flow limiting coronary artery disease or abnormal loading conditions. There are four...
Programme: H2020-EU.3.1.5.
Record Number: 216091
Last updated on: 2018-06-28
Personalised Medicine by Predictive Modeling in Stroke for better Quality of Life
ID: 777107
Data di inizio: 2018-05-01, Termine: 2022-04-30
Stroke is one of the most severe medical problems with far-reaching public health and socio-economic impact, gathering momentum in an ageing society. PRECISE4Q sets out to minimise the burden of stroke for the individual and for society. It will create multi-dimensional...
Programme: H2020-EU.3.1.5.
Record Number: 216090
Last updated on: 2018-06-27
IN-Silico trials for treatment of acute Ischemic STroke
ID: 777072
Data di inizio: 2017-11-01, Termine: 2021-10-31
Stroke is the number one cause of disability in the Western world and the 3rd most common cause of death. Despite new treatment options with intra-arterial thrombectomy, still 2 out of 3 patients still have a poor outcome. The main goal of INSIST is to advance treatments of...
Programme: H2020-EU.3.1.5.
Record Number: 212452
Last updated on: 2018-01-24
InSilc: In-silico trials for drug-eluting BVS design, development and evaluation
ID: 777119
Data di inizio: 2017-11-01, Termine: 2020-10-31
The aim of InSilc is to develop an in-silico clinical trial (ISCT) platform for designing, developing and assessing drug-eluting bioresorbable vascular scaffolds (BVS), by building on the comprehensive biological and biomedical knowledge and advanced modelling approaches to...
Programme: H2020-EU.3.1.5.
Record Number: 212941
Last updated on: 2018-01-24
In Silico Trial for Tuberculosis Vaccine Development
ID: 777123
Data di inizio: 2018-02-01, Termine: 2022-07-31
Tuberculosis (TB) one of the world’s deadliest diseases: one third of the world’s population, mostly in developing countries, is infected with TB. But TB is becoming again very dangerous also for developed countries, due to the increased mobility of the world population...
Programme: H2020-EU.3.1.5.
Record Number: 212940
Last updated on: 2018-01-24
An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes
ID: 777111
Data di inizio: 2018-02-01, Termine: 2023-01-31
Our programme will develop an innovative in-silico based approach to improve the efficacy and precision of drug repurposing trials. We have chosen drug repurposing as it has the shortest time for clinical validation and translation. Validation of all putatively de novo...
Programme: H2020-EU.3.1.5.
Record Number: 212939
Last updated on: 2018-01-24
Personalised Prognostic Models to Improve Well-being and Return to Work After Neck and Low Back Pain
ID: 777090
Data di inizio: 2018-01-01, Termine: 2020-12-31
Neck and low back pain (NLBP) are leading causes for years lived with disability in Europe and worldwide. About 70% of all adults experience NLBP at some point in their lives, and both conditions are among the top ten in terms of overall disease burden expressed as disability...
Programme: H2020-EU.3.1.5.
Record Number: 212455
Last updated on: 2017-10-31
Advanced personalised, multi-scale computer models preventing OsteoArthritis
ID: 777159
Data di inizio: 2017-11-01, Termine: 2020-10-31
Osteoarthritis (OA) is a degenerative disease of the articular cartilage and the most common form of arthritis that causes joint pain, mobility limitation and, thus, reduces independence and overall quality of life. Although the usual population associated with the condition...
Programme: H2020-EU.3.1.5.
Record Number: 212457
Last updated on: 2017-10-31
Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back
ID: 777167
Data di inizio: 2017-11-01, Termine: 2021-10-31
Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict resilience of women to...
Programme: H2020-EU.3.1.5.
Record Number: 212458
Last updated on: 2017-10-31
1
List retrieved on: 2018-11-17